Retina

Latest News

UK MHRA approves phase 2a study for ANXV for diabetic retinopathy
UK MHRA approves phase 2a study for ANXV for diabetic retinopathy

August 19th 2025

Annexin Pharmaceuticals initiates a Phase 2a study for ANXV in diabetic retinopathy to explore new treatment options and improve patient outcomes.

FDA clears IND for Opus Genetics’ OPGx-BEST1 gene therapy for inherited retinal disease
FDA clears IND for Opus Genetics’ OPGx-BEST1 gene therapy for inherited retinal disease

August 19th 2025

First patients dosed in JC02-88 study
First patients dosed in JC02-88 study

August 18th 2025

Boehringer Ingelheim and Palatin Technologies enter into a global research collaboration and licensing agreement
Boehringer Ingelheim and Palatin Technologies enter into a global research collaboration and licensing agreement

August 18th 2025

Video Interviews
Podcasts
EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
EyePod podcast: Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)
EyePod podcast: Innovation Series: How DMEI residents are shaping the future with smartphone imaging for retinal care (part 2)
EyePod podcast: DMEI residents Jibran Sharieff, MD, and Brandon Kingrey, MD, share their journey to innovation (part 1)
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
Assessing the Evidence for Extending Treatment Intervals in nAMD & DME Management: Expert Insights into Innovative Approaches
Ehsan Sadri, MD,  leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.